Best TWAS P=7.83e-17 · Best GWAS P=3.81e-15 conditioned to NaN
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | KRI1 | 0.30 | 0.39 | lasso | 3 | 0.38 | 1.7e-49 | -5.5 | 5.6 | 2.4e-08 | 0.14 | 1.00 | 0.00 | FALSE |
2 | GTEx | Adipose Subcutaneous | CDKN2D | 0.21 | 0.12 | lasso | 5 | 0.09 | 1.2e-07 | -6.7 | 6.7 | 2.8e-11 | 0.15 | 0.88 | 0.12 | FALSE |
3 | GTEx | Brain Frontal Cortex BA9 | KRI1 | 0.47 | 0.17 | lasso | 7 | 0.19 | 7.6e-06 | -5.6 | 6.7 | 2.6e-11 | 0.15 | 0.31 | 0.25 | FALSE |
4 | GTEx | Brain Hypothalamus | KRI1 | 0.29 | 0.17 | lasso | 3 | 0.20 | 1.5e-05 | -5.5 | 5.4 | 7.5e-08 | 0.11 | 0.20 | 0.12 | TRUE |
5 | GTEx | Cells EBV-transformed lymphocytes | PRDX2 | 0.26 | -0.01 | enet | 41 | 0.06 | 6.9e-03 | -3.5 | -5.3 | 1.4e-07 | 0.02 | 0.04 | 0.06 | FALSE |
6 | GTEx | Cells EBV-transformed lymphocytes | FARSA | 0.26 | 0.24 | lasso | 5 | 0.18 | 2.3e-06 | 4.8 | 5.1 | 2.9e-07 | 0.08 | 0.85 | 0.01 | FALSE |
7 | GTEx | Cells Transformed fibroblasts | ACP5 | 0.07 | 0.04 | lasso | 3 | 0.03 | 1.9e-03 | -5.3 | -5.4 | 6.6e-08 | 0.02 | 0.50 | 0.06 | TRUE |
8 | GTEx | Cells Transformed fibroblasts | MAN2B1 | 0.15 | 0.10 | enet | 17 | 0.08 | 2.7e-06 | 4.1 | -5.8 | 5.9e-09 | 0.03 | 0.99 | 0.00 | FALSE |
9 | GTEx | Cells Transformed fibroblasts | KRI1 | 0.18 | 0.16 | enet | 8 | 0.15 | 1.9e-11 | -5.6 | 6.8 | 8.4e-12 | 0.15 | 0.99 | 0.01 | FALSE |
10 | GTEx | Colon Sigmoid | KRI1 | 0.37 | 0.20 | lasso | 13 | 0.19 | 3.7e-07 | -5.6 | 5.8 | 7.1e-09 | 0.20 | 0.56 | 0.19 | FALSE |
11 | GTEx | Esophagus Gastroesophageal Junction | RNASEH2A | 0.21 | -0.01 | enet | 20 | 0.00 | 4.7e-01 | 2.2 | -5.5 | 3.1e-08 | 0.04 | 0.04 | 0.05 | TRUE |
12 | GTEx | Esophagus Mucosa | SMARCA4 | 0.18 | 0.03 | enet | 15 | 0.09 | 8.2e-07 | 4.5 | -5.5 | 3.4e-08 | -0.09 | 0.94 | 0.01 | FALSE |
13 | GTEx | Esophagus Muscularis | HOOK2 | 0.13 | 0.04 | lasso | 3 | 0.00 | 3.3e-01 | 5.9 | -6.3 | 3.7e-10 | -0.07 | 0.14 | 0.10 | TRUE |
14 | GTEx | Muscle Skeletal | KRI1 | 0.14 | 0.07 | lasso | 4 | 0.11 | 5.1e-11 | -5.6 | 7.0 | 3.1e-12 | 0.17 | 0.96 | 0.04 | FALSE |
15 | GTEx | Muscle Skeletal | SLC44A2 | 0.19 | 0.18 | lasso | 5 | 0.19 | 5.1e-18 | 5.6 | 6.3 | 3.7e-10 | 0.17 | 1.00 | 0.00 | TRUE |
16 | GTEx | Muscle Skeletal | CDKN2D | 0.12 | 0.09 | enet | 14 | 0.08 | 1.5e-08 | -6.7 | 5.9 | 2.9e-09 | 0.05 | 0.88 | 0.12 | FALSE |
17 | GTEx | Nerve Tibial | MAN2B1 | 0.14 | 0.01 | enet | 57 | 0.03 | 4.0e-03 | 4.1 | -5.4 | 8.0e-08 | -0.02 | 0.60 | 0.05 | FALSE |
18 | GTEx | Pituitary | GCDH | 0.42 | 0.30 | lasso | 5 | 0.29 | 4.2e-08 | 5.9 | 5.6 | 2.2e-08 | 0.07 | 0.83 | 0.04 | FALSE |
19 | GTEx | Small Intestine Terminal Ileum | CTC-425F1.4 | 0.26 | 0.13 | enet | 22 | 0.08 | 6.1e-03 | 2.7 | -5.8 | 7.0e-09 | -0.04 | 0.06 | 0.10 | FALSE |
20 | GTEx | Spleen | MAN2B1 | 0.33 | -0.01 | enet | 25 | 0.06 | 1.6e-02 | 3.6 | -6.2 | 6.1e-10 | -0.02 | 0.03 | 0.10 | FALSE |
21 | GTEx | Testis | MAN2B1 | 0.18 | 0.07 | enet | 21 | 0.11 | 1.9e-05 | 3.5 | -5.4 | 6.8e-08 | 0.01 | 0.90 | 0.00 | FALSE |
22 | GTEx | Testis | CDKN2D | 0.46 | 0.34 | lasso | 7 | 0.37 | 2.5e-17 | -6.7 | 6.0 | 2.2e-09 | 0.13 | 0.91 | 0.09 | FALSE |
23 | GTEx | Vagina | GCDH | 0.36 | 0.01 | lasso | 5 | 0.00 | 3.3e-01 | 5.9 | 5.5 | 3.0e-08 | 0.02 | 0.05 | 0.05 | FALSE |
24 | ROSMAP | Brain Pre-frontal Cortex | SLC44A2 | 0.08 | 0.00 | blup | 365 | 0.01 | 1.4e-02 | 3.4 | 5.6 | 2.2e-08 | -0.22 | 0.05 | 0.32 | TRUE |
25 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C19orf56 | 0.02 | 0.01 | blup | 23 | 0.01 | 1.0e-03 | 4.1 | -5.8 | 6.5e-09 | 0.05 | 0.06 | 0.07 | FALSE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | DNASE2 | 0.03 | 0.01 | enet | 9 | 0.01 | 5.5e-04 | -7.5 | -5.4 | 5.2e-08 | -0.02 | 0.00 | 0.96 | TRUE |
27 | The Cancer Genome Atlas | Breast Invasive Carcinoma | KRI1 | 0.03 | 0.02 | blup | 52 | 0.03 | 4.0e-06 | -5.5 | 7.3 | 2.5e-13 | 0.08 | 0.05 | 0.95 | FALSE |
28 | The Cancer Genome Atlas | Colon Adenocarcinoma | KRI1 | 0.06 | 0.02 | blup | 51 | 0.02 | 2.1e-02 | 3.2 | 6.3 | 2.8e-10 | 0.14 | 0.02 | 0.43 | TRUE |
29 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | KRI1 | 0.06 | 0.06 | lasso | 1 | 0.06 | 5.3e-07 | 6.8 | 6.8 | 1.2e-11 | 0.11 | 0.02 | 0.97 | TRUE |
30 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | MAN2B1 | 0.02 | 0.01 | blup | 26 | 0.02 | 3.1e-03 | 4.5 | -5.4 | 7.2e-08 | 0.02 | 0.04 | 0.10 | FALSE |
31 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | DNASE2 | 0.04 | 0.01 | enet | 6 | 0.02 | 1.1e-03 | -4.0 | -5.3 | 9.4e-08 | -0.09 | 0.02 | 0.06 | FALSE |
32 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | KRI1 | 0.05 | 0.05 | blup | 51 | 0.06 | 2.0e-07 | -5.6 | 6.1 | 1.0e-09 | 0.13 | 0.01 | 0.99 | FALSE |
33 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | LOC147727 | 0.13 | 0.02 | blup | 28 | 0.04 | 7.2e-05 | 6.3 | -6.3 | 3.5e-10 | -0.09 | 0.02 | 0.72 | FALSE |
34 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | MAST1 | 0.03 | 0.00 | blup | 47 | 0.01 | 2.5e-02 | -4.0 | -5.7 | 1.3e-08 | -0.12 | 0.03 | 0.04 | TRUE |
35 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | KEAP1 | 0.16 | 0.03 | blup | 31 | 0.03 | 6.2e-03 | -3.7 | 5.2 | 2.2e-07 | -0.42 | 0.01 | 0.05 | FALSE |
36 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | KRI1 | 0.09 | 0.04 | blup | 52 | 0.05 | 7.5e-04 | -5.6 | 5.4 | 7.3e-08 | -0.02 | 0.09 | 0.32 | FALSE |
37 | The Cancer Genome Atlas | Brain Lower Grade Glioma | LOC147727 | 0.07 | 0.02 | lasso | 2 | 0.02 | 5.4e-03 | 6.2 | -6.5 | 6.5e-11 | -0.15 | 0.02 | 0.66 | FALSE |
38 | The Cancer Genome Atlas | Brain Lower Grade Glioma | MAN2B1 | 0.13 | 0.09 | enet | 14 | 0.12 | 4.4e-13 | 3.5 | -5.8 | 6.3e-09 | 0.00 | 0.21 | 0.65 | FALSE |
39 | The Cancer Genome Atlas | Lung Adenocarcinoma | KRI1 | 0.05 | 0.04 | blup | 51 | 0.03 | 7.3e-05 | 6.9 | 8.3 | 7.8e-17 | 0.08 | 0.02 | 0.97 | TRUE |
40 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C19orf56 | 0.42 | 0.00 | lasso | 5 | 0.00 | 1.1e-01 | -4.0 | -6.5 | 8.6e-11 | 0.03 | 0.00 | 0.09 | FALSE |
41 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | KRI1 | 0.32 | 0.15 | enet | 7 | 0.19 | 4.8e-08 | -5.5 | 5.7 | 1.6e-08 | 0.12 | 0.22 | 0.64 | FALSE |
42 | The Cancer Genome Atlas | Prostate Adenocarcinoma | CDKN2D | 0.03 | 0.02 | blup | 48 | 0.01 | 2.1e-02 | -5.6 | 6.5 | 6.1e-11 | 0.13 | 0.02 | 0.90 | FALSE |
43 | The Cancer Genome Atlas | Prostate Adenocarcinoma | KRI1 | 0.12 | 0.14 | blup | 52 | 0.14 | 3.4e-14 | -5.6 | 5.4 | 8.5e-08 | 0.05 | 0.88 | 0.12 | FALSE |
44 | The Cancer Genome Atlas | Prostate Adenocarcinoma | ZGLP1 | 0.04 | 0.00 | blup | 48 | 0.02 | 3.5e-03 | 3.0 | -5.5 | 4.9e-08 | 0.44 | 0.00 | 0.19 | TRUE |
45 | The Cancer Genome Atlas | Soft Tissue Sarcoma | KRI1 | 0.05 | 0.06 | lasso | 3 | 0.04 | 3.1e-03 | 5.6 | 5.4 | 6.2e-08 | -0.03 | 0.03 | 0.39 | FALSE |
46 | The Cancer Genome Atlas | Soft Tissue Sarcoma | MAN2B1 | 0.40 | 0.08 | blup | 38 | 0.12 | 1.2e-07 | 3.1 | -6.9 | 5.2e-12 | 0.01 | 0.57 | 0.26 | TRUE |
47 | The Cancer Genome Atlas | Thyroid Carcinoma | SLC44A2 | 0.32 | 0.22 | enet | 14 | 0.25 | 3.8e-24 | 6.5 | 6.0 | 1.6e-09 | 0.07 | 0.14 | 0.86 | FALSE |